comparemela.com
Home
Live Updates
FDA Expands Label for Inclisiran to Include Adults With High
FDA Expands Label for Inclisiran to Include Adults With High
FDA Expands Label for Inclisiran to Include Adults With High LDL-C, Increased Risk of Heart Disease
The updated label for inclisiran (Leqvio) includes patients with comorbidities, such as hypertension and diabetes, who have yet to experience a cardiovascular event.
Related Keywords
Inclisiran Leqvio ,
Victor Bulto ,
Novartis ,
Novartis Innovative Medicines ,